Antidiabetic Agents and Endothelial Dysfunction – Beyond Glucose Control

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|117|1|15-25

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.117, Iss.1, 2015-07, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

By Mitchell Beth D.   Eby Elizabeth L.   Lage Maureen J.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1587-1597

Informa Healthcare

Access to resources Recommend Favorite

Endothelial dysfunction and cardiovascular disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 5-6, 2003-08 ,pp. : 274-277

Karger

Access to resources Recommend Favorite

A study of the anti-diabetic agents of camel milk

By        

International Journal of Molecular Medicine, Vol. 30, Iss. 3, 2012-01 ,pp. : 585-592

Spandidos Publications

Access to resources Recommend Favorite

Oral antidiabetic agents in type 2 diabetes

By Levetan Claresa  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 945-952

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone Prevents Capillary Rarefaction in Streptozotocin-Diabetic Rats Independently of Glucose Control and Vascular Endothelial Growth Factor Expression

By  

Journal of Vascular Research, Vol. 49, Iss. 3, 2012-03 ,pp. : 260-266

Karger

Access to resources Recommend Favorite